YORDY BRITO AGUILA: Open Payments
NPI 1033599246 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,728 in 145 payments from 29 companies in 2025. Trend: 2023 $3,460 · 2024 $3,038 · 2025 $3,728
Food & beverage: $3,728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $831 |
| PFIZER INC. | 19 | $433 |
| ABBVIE INC. | 21 | $343 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $192 |
| Novartis Pharmaceuticals Corporation | 3 | $180 |
| Exact Sciences Corporation | 7 | $174 |
| Amgen Inc. | 17 | $170 |
| Dexcom, Inc. | 2 | $167 |
| Insulet Corporation | 7 | $154 |
| Novo Nordisk Inc | 4 | $150 |
Products named: AIRSUPRA, QULIPTA, CAPLYTA, LEQVIO, FARXIGA, NURTEC ODT, Omnipod, DEXCOM G7 GSS (161).
Industry payments across FL — which companies pay providers there.
